QUANTUM EMOTION CORP (QNC)
NEW ERA ENERGY & DIGITAL, INC. (NUAI)
New Era Energy & Digital Announces Appointment of Andy Casazza as Chief Corporate Officer
OLEMA PHARMACEUTICALS, INC. (OLMA)
Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
ADAGENE INC. (ADAG)
Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types
HINGHAM INSTITUTION FOR SAVINGS (HIFS)
Hingham Savings Reports First Quarter 2026 Results
CARDIFF ONCOLOGY, INC. (CRDF)
Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting
XILIO THERAPEUTICS, INC. (XLO)
Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2